Next Article in Journal
A Comparison of Causative Pathogens in Bone and Prosthetic Joint Infections: Implications for Antimicrobial Therapy
Previous Article in Journal
A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolated from Bloodstream Infections in South Korea

Division of Antimicrobial Resistance Research, National Institute of Health, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si 28159, Republic of Korea
*
Author to whom correspondence should be addressed.
Antibiotics 2024, 13(12), 1124; https://doi.org/10.3390/antibiotics13121124 (registering DOI)
Submission received: 21 October 2024 / Revised: 11 November 2024 / Accepted: 21 November 2024 / Published: 23 November 2024

Abstract

:
Background/Objectives: Bloodstream infection by carbapenem-resistant Acinetobacter baumannii (CRAB) is a serious clinical problem worldwide. To study its clonal relationship and genetic features, we report the draft genome sequence of CRAB strains isolated from human blood in South Korea. Methods: Among A. baumannii strains isolated from patients at nine general hospitals in 2020, 12 CRAB strains of different genotypes were selected. Genomic DNA was sequenced using a combination of Illumina MiSeq and Oxford Nanopore MinION platforms. Antimicrobial susceptibility testing was performed using the disk diffusion method. Antimicrobial resistance and virulence genes were investigated in silico using the Center for Genomic Epidemiology server and the Virulence Factors Database. Results: The multilocus sequence types of isolates included ST191, ST195, ST357, ST369, ST451, ST469, ST491, ST784, ST862, ST1933, ST2929, and a novel type, ST3326. The predominant sequence type, ST191, demonstrated close genetic relationships with several isolates, including ST469, ST369, ST195, ST784, ST491, and ST3326, with ST3326 classified as a subgroup of ST191. We found 18 antimicrobial resistance genes and one quaternary ammonium compound resistance gene. All examined strains harbored blaOXA-23, which is associated with carbapenem resistance. While variations in antibiotic and disinfectant resistance genes were observed, all isolates exhibited similar virulence factors, with the exception of the biofilm and capsule production genes. Conclusions: This nationwide report of the draft genome sequence of patient-derived strains provides valuable insights into the genomic features associated with clonal relationships and antimicrobial resistance of CRAB in bloodstream infections.

1. Introduction

Acinetobacter baumannii, a gram-negative pathogen, is a significant cause of hospital-acquired infections, including central line-associated bloodstream infections and ventilator-associated pneumonia [1,2]. A. baumannii infection is associated with increased mortality rates, as its high resistance to conventional treatments complicates the management of infections, potentially leading to an increase in fatality rates [2]. Carbapenem-resistant A. baumannii outbreaks often involve genetically similar strains, making multilocus sequence typing (MLST) a valuable tool for studying their spread. There are two primary MLST schemes for A. baumannii: the Oxford scheme, which distinguishes between closely related strains, and the Pasteur scheme, useful for studying the broader population structure and epidemiology of A. baumannii and related bacteria. In certain cases, the outcomes vary depending on the MLST type [1]. Carbapenems, crucial last-resort antibiotics, are effective against multidrug-resistant bacteria; however, the rise of carbapenem-resistant A. baumannii (CRAB) is a global concern. The World Health Organization has, since 2017, classified it as a priority 1 critical pathogen, particularly prevalent in intensive care units (ICUs) [3]. In Korea, ST191 was the most common CRAB type in ICUs from 2016 to 2017, with a notably high 30-day mortality rate [4]. Recently, ST369, showing stronger pathogenicity in mouse infection experiments, emerged. ST369 exhibits a higher incidence rate of CRAB bacteremia, a shorter time to bacteremia following ICU admission, and a greater early mortality rate, which may be attributed to its enhanced competitive growth rate and increased virulence compared to ST191 [1]. Despite the importance of epidemiological surveillance, genomic data on CRAB in Korea are lacking. Here, we report the draft genome sequence of diverse CRAB strains to elucidate its genomic features.

2. Results

2.1. Genome Assembly Quality

The genome sizes of the 12 CRAB strains ranged between 3,856,432 and 4,121,232 bp, with an average coverage of 524.207–707.341× and a GC content of 38.86–39.11%. The genome comprised 3621–3958 predicted protein-coding sequences, 72–74 tRNA genes, and 18 rRNA genes. Details of the assembly quality are provided in Table S1.

2.2. Sequence Types and Phylogenetic Tree

Classification of the isolates by whole-genome multilocus sequence typing (wgMLST) yielded ST191, 195, 357, 369, 451, 469, 491, 784, 862, 1933, and 2929. G20AB08 was classified as a new sequence type (ST3326) based on novel combinations of the seven alleles (Table S2).
The ANI tree analysis revealed differences among sequence types ST491, ST862, and ST2929, while the remaining types exhibited similar sequences (Figure 1). ST191 was found to be associated with ST469, 369, 195, 784, 491, and 3326.

2.3. Antimicrobial Resistance Genes

Identification of antimicrobial resistance determinants from the whole-genome sequencing (WGS) data revealed various antimicrobial resistance genes, predicting resistance to several antimicrobial classes, as shown in Figure 2. All the 12 CRAB isolates carried the blaOXA-23 gene, which is associated with carbapenem resistance. For aminoglycoside resistance, the armA gene was present in seven isolates; aadA1 in six isolates; aph(6)-Id in five isolates; and aph(3′)-Ia, aph(3′)-Via, and aac(3)-Ia were each found in two isolates. Additionally, the msr(E) gene, linked to macrolide resistance, was found in six isolates, and the tet(B) gene, associated with tetracycline resistance, was present in five isolates. The sul1 and sul2 genes, which are related to sulfonamide resistance, were detected in seven and two isolates, respectively. Finally, the catB8 gene, which may confer resistance to amphenicol, was observed in five isolates. Additionally, the qacE gene, which provides resistance to quaternary ammonium compounds used as disinfectants, was detected in seven isolates.

2.4. Virulence-Associated Genes

The investigation of virulence factors in all CRAB isolates identified genes associated with acinetobactin, trimeric autotransporters, biofilm formation, capsule production, HemO clusters, lipopolysaccharide, and outer membrane protein A (OmpA). Notably, variations in the biofilm, capsule, HemO cluster, and quorum sensing genes were observed across different A. baumannii sequence types. Details on virulence-associated genes and the results are presented in Figure 3.

3. Discussion

Within Asia, South Korea has been reported to have a relatively high proportion of drug-resistant A. baumannii strains, including CRAB and MDRAB (>93.0%) [5]. Therefore, we employed WGS to characterize the genomes of 12 CRAB isolates collected from hospitals in South Korea.
Among the collected isolates, differences were noted between sequence types ST491, ST862, and ST2929, whereas the remaining types showed similar sequences. ST191, the most prevalent sequence type reported in Korean ICUs and wards from 2016 to 2017 [4], was found to be closely related to several other isolates, including ST469, ST369, ST195, ST784, ST491, and ST3326. The newly classified ST3326 was identified as a subgroup of ST191, while ST357 was classified as a subgroup of ST3326.
All isolates exhibited characteristics of carbapenem resistance by harboring the blaOXA-23 gene, a carbapenemase gene that contributes to this resistance in the CRAB isolates. Similarly, the carbapenem resistance rate of A. baumannii strains isolated in Korea was recently reported to be 87.4%, with blaOXA-23 present in all strains [6]. According to a recent study, most (98.7%) of the CRAB isolates collected in Korea harbor the blaOXA-23 gene, while only a small number (1.3%) have the non-blaOXA-23 gene [7]. In this study, no isolates with the non-blaOXA-23 gene were found. Most of the isolates exhibited resistance to aminoglycosides. Aminoglycosides are frequently used as a treatment for CRAB, either alone or in combination with other antibiotics, such as polymixin and carbapenem [8,9,10]. armA (16S rRNA methyltransferase) was previously found in 80.2% of CRAB isolates in Korea [11]. This study also showed the presence of armA in most CRAB isolates (ST191, ST195, ST369, ST451, ST469, ST784, and ST3326).
Most isolates are susceptible to tigecycline (Table S3), but tigecycline is not recommended for the treatment of CRAB infections [12,13]. Colistin is used as a last-resort antibiotic against CRAB, but only the ST369 strain among isolates was found to be resistant to colistin (Table S3). QacE, which confers resistance to disinfectants via quaternary ammonium compounds, was found in ST369, ST191, ST491, ST784, ST469, ST2929, and ST3326. The differences in antibiotic resistance and disinfectant resistance genes may influence the spread of A. baumannii infections by overcoming infection prevention and control measures within the hospital environment.
Although the antibiotic and disinfectant resistance genes varied among the isolates, all domestic A. baumannii strains shared similar virulence factors, with the exception of genes related to biofilm formation and capsule production. The biofilm and capsule are well-established important virulence factors of A. baumannii. The ability to form biofilms contributes to the survival and transmissibility of A. baumannii in hospital environments, protects the microorganisms, and enhances resistance to various antibiotics [14,15]. Capsule formation significantly affects in vivo virulence by increasing resistance to desiccants, disinfectants, antimicrobials, and antibiotics [16]. Although detected in all isolates, galU and galE, which are associated with capsule production, are considered an important virulence factor in a number of Gram-negative pathogens [17,18,19]. Differences in these virulence factor-related genes, along with antibiotic resistance, may play a crucial role in the survival of A. baumannii. However, the pathogenicity of A. baumannii is influenced by various factors beyond the major virulence determinants. This is evident in the observation that, despite having the same major virulence factors, differences in virulence were observed between ST191 and ST369 [1]. Although these strains are phylogenetically similar, the ST369 strain is known to exhibit higher virulence and a faster growth rate than ST191 [1]. In this study, whole-genome comparison analysis revealed that the OmpA gene [20], a major virulence factor in A. baumannii, showed no differences between ST191 and ST369. Furthermore, the wzc gene [21], associated with the adhesiveness of A. baumannii, did not exhibit significant amino acid substitutions, such as G540A and G667D.
This study provides comparative genomic insights into bloodstream-infecting CRAB strains in Korea, serving as a foundation for future comparative genomic studies on the evolution and spread of this pathogen in human populations.

4. Materials and Methods

4.1. Strain Information

In 2020, CRAB strains were isolated from patient blood samples across nine general hospitals from the nationwide Korea Global AMR Surveillance System (Kor-GLASS). A. baumannii was isolated from blood using automated equipment, such as BaCT/ALERT (bioMérieux, Marcy l’Étoile, France). Bacterial testing from blood samples was routinely conducted for treatment purposes in ICUs and similar settings. After enrichment on tryptic soy agar at 37 °C (Becton Dickinson, Sparks, MD, USA), the strains were identified as A. baumannii using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (bioMérieux, Marcy l’Étoile, France). In the 2020 Kor-GLASS project, 160 CRAB strains were classified into 12 MLST types, and 1 CRAB strain was randomly selected from each MLST type for WGS analysis.

4.2. Antimicrobial Susceptibility Testing

Antimicrobial susceptibility was assessed via the disk diffusion method, following the CLSI 2023 guidelines. The minimum inhibitory concentration values for imipenem and colistin were determined using the microplate dilution method with a Panel KRCDC2F (Thermo Fisher Scientific, TREK Diagnostic Systems, Cleveland, OH, USA).

4.3. WGS

The draft genome sequences of the 12 strains were obtained via combined analysis using the MiSeq system from Illumina and the MinION system with FLO-MIN114 from Oxford Nanopore Technologies at ONEOMICS (Gimpo-si, Gyeonggi-do, Korea).

4.4. Assembly, Annotation, and Characterization of Genome Sequences

Raw sequences were processed using trim_galore software v0.6.7 to collect, filter, and clean the data. De novo genome assembly was performed using the multi-platform genome assembly process (MpGAP) v3.1, using Nextflow version 21.10.6 and Masurca version 4.0.5. Gene prediction utilized ab initio methods, including Augustus v3.0, HiQ v1.0, GlimmerHMM v3.0.4, snap v2.5.5, and GeneMark2 v3.01.03. Annotation was conducted using InterProScan v5.63-95.0. Antimicrobial resistance and virulence genes were analyzed using the Center for Genomic Epidemiology ResFinder and virulence factor database (http://www.mgc.ac.cn/VFs/) accessed on 11 July 2024. The draft genome sequences of the 12 A. baumannii isolates were compared using wgMLST (https://github.com/bvalot/pyMLST) accessed on 5 July 2024, with ATCC 17978 serving as the reference strain.

5. Conclusions

In this study, we investigated the genetic diversity of CRAB strains linked to bloodstream infections in South Korea. The predominant sequence type, ST191, was found to have close genetic relationships with several other isolates, including ST469, ST369, ST195, ST784, ST491, and ST3326, with ST3326 classified as a subgroup of ST191. All examined strains harbored the blaOXA-23 gene, which is associated with carbapenem resistance. While variations in antibiotic and disinfectant resistance genes were observed, all isolates exhibited similar virulence factors. These results highlight the need for ongoing research to elucidate the evolution and transmission dynamics of this pathogen, informing effective therapeutic approaches and infection control strategies.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics13121124/s1, Table S1: Genetic characteristics of 12 carbapenem-resistant A. baumannii isolates from bloodstream infections; Table S2: MLST analysis of 12 carbapenem-resistant A. baumannii isolates from bloodstream infections; Table S3: Antimicrobial susceptibility profiles of 12 carbapenem-resistant A. baumannii isolates from bloodstream infections.

Author Contributions

Y.J.K., J.H.S. and W.J.J. performed the experiment; Y.J.K. and J.H.S. performed the sequencing; W.J.J., D.C.M. and J.S.Y. analyzed the data and wrote the manuscript; J.S.Y. and D.C.M. supervised the project and obtained funding. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the National Institute of Health (NIH) research project (project No. 2023-NS-004-00).

Institutional Review Board Statement

The research, which did not involve human subjects but did use clinical isolates, qualified as an exempt category not needing approval from the Ethics Committee on Human Research of the Health Ministry in South Korea, and the study design was not reviewed by the committee.

Informed Consent Statement

The requirement for patient consent was waived because the human samples were collected as part of routine procedures, and all patient data were anonymized.

Data Availability Statement

The complete genome sequence of isolates has been deposited in GenBank with the accession no. CP142895, CP143269, CP142101, CP142801, CP142102, CP142660, CP143262, CP142645, CP142642, CP145430, CP146812, and CP146231.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Kim, S.E.; Choi, S.-M.; Yu, Y.; Shin, S.U.; Oh, T.H.; Kang, S.-J.; Park, K.-H.; Shin, J.H.; Kim, U.J.; Jung, S.I. Replacement of the dominant ST191 clone by ST369 among carbapenem-resistant Acinetobacter baumannii Bloodstream Isolates at a Tertiary Care Hospital in South Korea. Front. Microbiol. 2022, 13, 949060. [Google Scholar] [CrossRef] [PubMed]
  2. Siempos, I.I.; Vardakas, K.Z.; Kyriakopoulos, C.E.; Ntaidou, T.K.; Falagas, M.E. Predictors of mortality in adult patients with ventilator-associated pneumonia. Shock 2010, 33, 590–601. [Google Scholar] [CrossRef] [PubMed]
  3. Munoz-Price, L.S.; Arheart, K.; Nordmann, P.; Boulanger, A.E.; Cleary, T.; Alvarez, R.; Pizano, L.; Namias, N.; Kett, D.H.; Poirel, L. Eighteen years of experience with Acinetobacter baumannii in a tertiary care hospital. Crit. Care Med. 2013, 41, 2733–2742. [Google Scholar] [CrossRef] [PubMed]
  4. Yoon, E.-J.; Kim, D.; Lee, H.; Lee, H.S.; Shin, J.H.; Uh, Y.; Shin, K.S.; Kim, Y.A.; Park, Y.S.; Shin, J.H.; et al. Counter clinical prognoses of patients with bloodstream infections between causative Acinetobacter baumannii clones ST191 and ST451 belonging to the International Clonal Lineage II. Front. Public Health 2019, 7, 233. [Google Scholar] [CrossRef] [PubMed]
  5. Chen, C.-H.; Wu, P.-H.; Lu, M.-C.; Ho, M.-W.; Hsueh, P.-R. Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific Region: Results from the antimicrobial testing leadership and surveillance (ATLAS) program, 2020. Int. J. Antimicrob. Agents 2023, 61, 106707. [Google Scholar] [CrossRef]
  6. Bae, I.K.; Hong, J.S. The distribution of carbapenem-resistant Acinetobacter species and high prevalence of CC92 OXA-23-producing Acinetobacter baumannii in community hospitals in South Korea. Infect. Drug Resist. 2024, 17, 1633–1641. [Google Scholar] [CrossRef]
  7. Kim, Y.A.; Jeong, S.H.; Shin, J.H.; Shin, K.S.; Shin, J.H.; Kim, Y.R.; Kim, H.S.; Uh, Y.; Ryoo, N.H. Four genotypes of carbapenem-resistant Acinetobacter baumannii strains lacking OXA-23 production in Korea. Ann. Clin. Microbiol. 2024, 27, 143–147. [Google Scholar] [CrossRef]
  8. Papst, L.; Beović, B.; Pulcini, C.; Durante-Mangoni, E.; Rodríguez-Baño, J.; Kaye, K.S.; Daikos, G.L.; Raka, L.; Paul, M.; ESGAP, ESGBIS, ESGIE and the CRGNB treatment survey study group. Antibiotic treatment of infections caused by carbapenem-resistant gram-negative Bacilli: An international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clin. Microbiol. Infect. 2018, 24, 1070–1076. [Google Scholar] [CrossRef]
  9. Petrosillo, N.; Giannella, M.; Antonelli, M.; Antonini, M.; Barsic, B.; Belancic, L.; Inkaya, A.C.; De Pascale, G.; Grilli, E.; Tumbarello, M.; et al. Clinical experience of colistin-glycopeptide combination in critically Ill patients infected with gram-negative bacteria. Antimicrob. Agents Chemother. 2013, 58, 851–858. [Google Scholar] [CrossRef]
  10. Yadav, R.; Landersdorfer, C.B.; Nation, R.L.; Boyce, J.D.; Bulitta, J.B. Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2015, 59, 2286–2298. [Google Scholar] [CrossRef]
  11. Jun, S.H.; Lee, D.E.; Hwang, H.R.; Kim, N.; Kim, H.J.; Lee, Y.C.; Kim, Y.K.; Lee, J.C. Clonal change of carbapenem-resistant Acinetobacter baumannii isolates in a Korean hospital. Infect. Genet. Evol. 2021, 93, 104935. [Google Scholar] [CrossRef] [PubMed]
  12. Li, J.; Fu, Y.; Zhang, J.; Wang, Y.; Zhao, Y.; Fan, X.; Yu, L.; Wang, Y.; Zhang, X.; Li, C. Efficacy of tigecycline monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant Acinetobacter baumannii sequence type 2 in Heilongjiang province. Ann. Palliat. Med. 2019, 8, 651–659. [Google Scholar] [CrossRef] [PubMed]
  13. Kim, N.-H.; Hwang, J.-H.; Song, K.-H.; Choe, P.G.; Kim, E.S.; Park, S.-W.; Kim, H.B.; Kim, N.J.; Park, W.B.; Oh, M.-D. Tigecycline in carbapenem-resistant Acinetobacter baumannii Bacteraemia: Susceptibility and clinical outcome. Scand. J. Infect. Dis. 2013, 45, 315–319. [Google Scholar] [CrossRef]
  14. Upmanyu, K.; Haq, Q.; Mohd, R.; Singh, R. Factors mediating Acinetobacter baumannii biofilm formation: Opportunities for developing therapeutics. Curr. Res. Microb. Sci. 2022, 3, 100131. [Google Scholar] [CrossRef] [PubMed]
  15. Mohamed, E.A.; Raafat, M.M.; Mohamed, R.S.; Ali, A.E.E. Acinetobacter baumannii biofilm and its potential therapeutic targets. Futur. J. Pharm. Sci. 2023, 9, 82. [Google Scholar] [CrossRef]
  16. Tipton, K.A.; Chin, C.-Y.; Farokhyfar, M.; Weiss, D.S.; Rather, P.N. Role of capsule in resistance to disinfectants, host antimicrobials, and desiccation in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2018, 62, 10–1128. [Google Scholar] [CrossRef]
  17. Nesper, J.; Lauriano, C.M.; Klose, K.E.; Kapfhammer, D.; Kraiß, A.; Reidl, J. Characterization of Vibrio cholerae O1 El TorgalU and galE mutants: Influence on lipopolysaccharide structure, colonization, and biofilm formation. Infect. Immun. 2001, 69, 435–445. [Google Scholar] [CrossRef]
  18. Guo, Y.; Sagaram, U.S.; Kim, J.; Wang, N. Requirement of the galU gene for polysaccharide production by and pathogenicity and growth in planta of Xanthomonas citri Subsp. Citri. Appl. Environ. Microbiol. 2010, 76, 2234–2242. [Google Scholar] [CrossRef]
  19. Vilches, S.; Canals, R.; Wilhelms, M.; Saló, M.T.; Knirel, Y.A.; Vinogradov, E.; Merino, S.; Tomás, J.M. Mesophilic Aeromonas UDP-glucose pyrophosphorylase (GalU) mutants show two types of lipopolysaccharide structures and reduced virulence. Microbiology 2007, 153, 2393–2404. [Google Scholar] [CrossRef]
  20. Choi, C.H.; Hyun, S.H.; Lee, J.Y.; Lee, J.S.; Lee, Y.S.; Kim, S.A.; Chae, J.; Yoo, S.M.; Lee, J.C. Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity. Cell Microbiol. 2008, 10, 309–319. [Google Scholar] [CrossRef]
  21. Huang, Y.; Ali, M.R.; Li, W.; Wang, W.; Dai, Y.; Lu, H.; He, Z.; Li, Y.; Sun, B. Epidemiological characteristics of multidrug- resistant Acinetobacter baumannii ST369 in Anhui, China. mSystems 2023, 8, e00731-23. [Google Scholar] [CrossRef] [PubMed]
Figure 1. wgMLST (OXFORD)-based phylogeny of 12 A. baumannii isolates. A. baumannii isolates are depicted as circles interconnected by branches whose lengths correspond to the allelic distance.
Figure 1. wgMLST (OXFORD)-based phylogeny of 12 A. baumannii isolates. A. baumannii isolates are depicted as circles interconnected by branches whose lengths correspond to the allelic distance.
Antibiotics 13 01124 g001
Figure 2. Antimicrobial resistance gene patterns in 12 carbapenem-resistant A. baumannii isolates from bloodstream infections.
Figure 2. Antimicrobial resistance gene patterns in 12 carbapenem-resistant A. baumannii isolates from bloodstream infections.
Antibiotics 13 01124 g002
Figure 3. Pattern of virulence factors in the 12 carbapenem-resistant A. baumannii isolates from bloodstream infections.
Figure 3. Pattern of virulence factors in the 12 carbapenem-resistant A. baumannii isolates from bloodstream infections.
Antibiotics 13 01124 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jeon, W.J.; Kim, Y.J.; Seo, J.H.; Yoo, J.S.; Moon, D.C. Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolated from Bloodstream Infections in South Korea. Antibiotics 2024, 13, 1124. https://doi.org/10.3390/antibiotics13121124

AMA Style

Jeon WJ, Kim YJ, Seo JH, Yoo JS, Moon DC. Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolated from Bloodstream Infections in South Korea. Antibiotics. 2024; 13(12):1124. https://doi.org/10.3390/antibiotics13121124

Chicago/Turabian Style

Jeon, Wook Jong, Yoo Jung Kim, Ju Hui Seo, Jung Sik Yoo, and Dong Chan Moon. 2024. "Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolated from Bloodstream Infections in South Korea" Antibiotics 13, no. 12: 1124. https://doi.org/10.3390/antibiotics13121124

APA Style

Jeon, W. J., Kim, Y. J., Seo, J. H., Yoo, J. S., & Moon, D. C. (2024). Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolated from Bloodstream Infections in South Korea. Antibiotics, 13(12), 1124. https://doi.org/10.3390/antibiotics13121124

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop